Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2014 09:22 ET | Source: Immunovaccine Inc.

Immunovaccine Raises Total of $11.2 Million in Public Offering and Private Placement

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 4, 2014) - NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES Immunovaccine Inc....
August 26, 2014 14:09 ET | Source: Immunovaccine Inc.

Immunovaccine Upsizes and Prices Its Previously Announced Public Offering

HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 26, 2014) - NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES Immunovaccine Inc....
August 25, 2014 10:30 ET | Source: Immunovaccine Inc.

Ebola Vaccine Using Immunovaccine's DepoVax Proves Highly Efficacious in Non-Human Primate Study

HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 25, 2014) - Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE:IMV), a clinical stage vaccine company, today announced positive results for a...
August 15, 2014 08:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Financial Results for Quarter Ended June 30, 2014

HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 15, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...
August 12, 2014 08:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at Ninth Annual Immunotherapies and Vaccines Summit (ImVacS) Conference

HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 12, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, announced today that Marc Mansour,...
June 11, 2014 09:18 ET | Source: Immunovaccine Inc.

Immunovaccine Appoints Marc Mansour as Chief Executive Officer

HALIFAX, NOVA SCOTIA--(Marketwired - June 11, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
June 02, 2014 08:05 ET | Source: Immunovaccine Inc.

Immunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014

HALIFAX, NOVA SCOTIA--(Marketwired - June 2, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, presented positive results from a...
May 28, 2014 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Financial Results for Quarter Ended March 31, 2014

HALIFAX, NOVA SCOTIA--(Marketwired - May 28, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...
May 20, 2014 08:05 ET | Source: Immunovaccine Inc.

Immunovaccine's Novel Immunotherapy Triggers Partial Response and Generates Potent Immune Responses in Ovarian Cancer Clinical Study

HALIFAX, NOVA SCOTIA--(Marketwired - May 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, announced today that new positive...
May 12, 2014 17:31 ET | Source: Immunovaccine Inc.

Immunovaccine Clarifies May 12, 2014 Trading Activity

HALIFAX, NOVA SCOTIA--(Marketwired - May 12, 2014) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES Immunovaccine Inc. ("Immunovaccine" or...